• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.血清胆红素水平、UGT1A1基因多态性与冠状动脉疾病风险
Exp Gerontol. 2008 Dec;43(12):1102-7. doi: 10.1016/j.exger.2008.08.047. Epub 2008 Aug 26.
2
The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography.UGT1A1*28 基因变异可预测行冠状动脉造影术患者的长期死亡率。
Clin Chem Lab Med. 2018 Mar 28;56(4):560-564. doi: 10.1515/cclm-2017-0692.
3
Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han population.中国汉族人群中四种胆红素代谢基因的常见变异及其与血清胆红素和冠状动脉疾病的关联
Pharmacogenet Genomics. 2009 Apr;19(4):310-8. doi: 10.1097/FPC.0b013e328328f818.
4
Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study.间歇性跛行患者中UGT1A1 TA重复多态性与胆红素浓度的关联:CAVASIC研究结果
Clin Chem. 2008 May;54(5):851-7. doi: 10.1373/clinchem.2007.102046. Epub 2008 Mar 28.
5
Polymorphisms of the uridine-diphosphoglucuronosyltransferase 1A1 gene and coronary artery disease.尿苷二磷酸葡萄糖醛酸基转移酶1A1基因多态性与冠状动脉疾病
Cell Mol Biol Lett. 2008;13(1):1-10. doi: 10.2478/s11658-007-0030-1. Epub 2007 Oct 19.
6
Bilirubin UDP-glucuronosyltransferase 1A1 gene polymorphisms: susceptibility to oxidative damage and cancer?胆红素UDP-葡萄糖醛酸基转移酶1A1基因多态性:对氧化损伤和癌症的易感性?
Mol Carcinog. 2000 Dec;29(4):198-204.
7
UDP-glucuronosyltransferase 1A1 (UGT1A1) gene haplotypes and their effect on serum bilirubin concentration in healthy Indian adults.UDP-葡糖醛酸基转移酶 1A1(UGT1A1)基因单倍型及其对健康印度成年人血清胆红素浓度的影响。
Gene. 2013 Jan 15;513(1):36-9. doi: 10.1016/j.gene.2012.10.081. Epub 2012 Nov 9.
8
UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.白种人和亚洲人中尿苷二磷酸葡萄糖醛酸基转移酶(UGT1A1*28和UGT1A6*2)基因多态性:与血清胆红素浓度的关系
Pharmacogenetics. 1999 Jun;9(3):341-9. doi: 10.1097/00008571-199906000-00009.
9
Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers.UGT1A1基因中的单倍型及其作为健康德国志愿者胆红素浓度遗传决定因素的作用。
Clin Biochem. 2009 Nov;42(16-17):1635-41. doi: 10.1016/j.clinbiochem.2009.08.011. Epub 2009 Sep 2.
10
Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer.血清胆红素与 HMOX1 和 UGT1A1 基因启动子变异在散发性结直肠癌中的相关性。
Int J Cancer. 2012 Oct 1;131(7):1549-55. doi: 10.1002/ijc.27412. Epub 2012 Feb 18.

引用本文的文献

1
Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome.胆红素在肠-肝-肾轴中生物转化为尿胆素:心血管-肾脏-代谢(CKM)综合征中胰岛素抵抗的生物标志物。
Metabolism. 2025 Feb;163:156081. doi: 10.1016/j.metabol.2024.156081. Epub 2024 Nov 22.
2
Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population.泰国人群全基因组测序获得的 51 个药物基因的基因型和表型图谱。
PLoS One. 2022 Feb 17;17(2):e0263621. doi: 10.1371/journal.pone.0263621. eCollection 2022.
3
Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy.血清巯基、丙二醛、尿酸和胆红素作为缺血性或非缺血性心肌病心力衰竭患者不良预后的预测因子。
Oxid Med Cell Longev. 2021 Apr 15;2021:6693405. doi: 10.1155/2021/6693405. eCollection 2021.
4
Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients.肝功能之外的指标-胆红素在慢性肾脏病患者中可作为潜在的心血管保护因子。
Int J Mol Sci. 2018 Dec 29;20(1):117. doi: 10.3390/ijms20010117.
5
Bilirubin in coronary artery disease: Cytotoxic or protective?冠状动脉疾病中的胆红素:细胞毒性还是具有保护作用?
World J Gastrointest Pharmacol Ther. 2016 Nov 6;7(4):469-476. doi: 10.4292/wjgpt.v7.i4.469.
6
Serum bilirubin concentration is modified by UGT1A1 haplotypes and influences risk of type-2 diabetes in the Norfolk Island genetic isolate.血清胆红素浓度受UGT1A1单倍型影响,并影响诺福克岛遗传隔离人群中2型糖尿病的发病风险。
BMC Genet. 2015 Dec 2;16:136. doi: 10.1186/s12863-015-0291-z.
7
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.全基因组关联研究总胆红素与镰状细胞贫血胆石症风险的关系。
PLoS One. 2012;7(4):e34741. doi: 10.1371/journal.pone.0034741. Epub 2012 Apr 27.
8
Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.印度南部人群 TPMT、UGT1A1 和 MDR1 基因分子变异型的种间和种内分布差异。
Mol Biol Rep. 2012 May;39(5):6343-51. doi: 10.1007/s11033-012-1456-8. Epub 2012 Feb 9.
9
Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.梅奥基因组联盟:用于全基因组关联研究的基因型-表型资源,及其在分析循环胆红素水平中的应用。
Mayo Clin Proc. 2011 Jul;86(7):606-14. doi: 10.4065/mcp.2011.0178. Epub 2011 Jun 6.
10
Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.血清胆红素与 UGT1A1*28 多态性相关,并可预测慢性血液透析患者的长期心血管事件和死亡率。
Clin J Am Soc Nephrol. 2011 Mar;6(3):567-74. doi: 10.2215/CJN.06130710.

本文引用的文献

1
Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study.间歇性跛行患者中UGT1A1 TA重复多态性与胆红素浓度的关联:CAVASIC研究结果
Clin Chem. 2008 May;54(5):851-7. doi: 10.1373/clinchem.2007.102046. Epub 2008 Mar 28.
2
Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.吉尔伯特综合征、UGT1A1*28等位基因与心血管疾病风险:胆红素可能的保护作用及治疗应用
Atherosclerosis. 2008 May;198(1):1-11. doi: 10.1016/j.atherosclerosis.2008.01.001. Epub 2008 Mar 17.
3
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.对14000例七种常见疾病患者及3000例共享对照进行全基因组关联研究。
Nature. 2007 Jun 7;447(7145):661-78. doi: 10.1038/nature05911.
4
UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women.不同种族女性队列中尿苷二磷酸葡萄糖醛酸基转移酶1A1基因多态性与总胆红素水平
Drug Metab Dispos. 2007 Aug;35(8):1254-61. doi: 10.1124/dmd.106.014183. Epub 2007 May 3.
5
Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME).心肌梗死前瞻性流行病学研究(PRIME)中的胆红素与冠心病风险
Eur J Cardiovasc Prev Rehabil. 2007 Feb;14(1):79-84. doi: 10.1097/01.hjr.0000230097.81202.9f.
6
The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases.血红素分解代谢途径及其对氧化应激介导疾病的保护作用。
Adv Clin Chem. 2007;43:1-57. doi: 10.1016/s0065-2423(06)43001-8.
7
Further evidence that the UGT1A1*28 allele is not associated with coronary heart disease: The ECTIM Study.
Clin Chem. 2006 Dec;52(12):2313-4. doi: 10.1373/clinchem.2006.078667.
8
Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study.弗雷明汉心脏研究中UGT1A1*28等位基因、胆红素水平与冠心病之间的关联。
Circulation. 2006 Oct 3;114(14):1476-81. doi: 10.1161/CIRCULATIONAHA.106.633206. Epub 2006 Sep 25.
9
The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes.脂肪甘油三酯脂肪酶基因与游离脂肪酸、甘油三酯及2型糖尿病相关。
Diabetes. 2006 May;55(5):1270-5. doi: 10.2337/db05-1498.
10
High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions.高血清胆红素浓度可维持冠状动脉血流储备和冠状动脉微血管功能。
Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2289-94. doi: 10.1161/01.ATV.0000185806.61430.7c. Epub 2005 Sep 8.

血清胆红素水平、UGT1A1基因多态性与冠状动脉疾病风险

Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

作者信息

Lingenhel Arno, Kollerits Barbara, Schwaiger Johannes P, Hunt Steven C, Gress Richard, Hopkins Paul N, Schoenborn Veit, Heid Iris M, Kronenberg Florian

机构信息

Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Schöpfstrasse 41, A-6020 Innsbruck, Austria.

出版信息

Exp Gerontol. 2008 Dec;43(12):1102-7. doi: 10.1016/j.exger.2008.08.047. Epub 2008 Aug 26.

DOI:10.1016/j.exger.2008.08.047
PMID:18790042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2648823/
Abstract

Low levels of the antioxidative serum bilirubin are associated with vascular aging and an increased risk for coronary artery disease (CAD). UGT1A1 is the major gene influencing bilirubin concentrations. Therefore, we investigated an association of bilirubin levels and two polymorphisms in the promoter of UGT1A1 (-53(TA-repeat) polymorphism and T-3279G) in 477 patients with premature, familial CAD and 619 age- and sex-matched controls. Bilirubin concentrations were significantly lower in cases than in controls (0.62+/-0.36 vs. 0.76+/-0.41 mg/dl for men, p=1.2 x 10(-10); and 0.42+/-0.29 vs. 0.55+/-0.23 mg/dl, p=1.9 x 10(-9) for women). Both polymorphisms showed a strong association with bilirubin levels with higher levels for homozygote carriers of the minor allele. These associations were most pronounced in male controls and patients (p=5.9 x 10(-26) and p=3.4 x 10(-16), respectively, for the -53(TA-repeat) polymorphism). Logistic regression analysis revealed low bilirubin levels but not the UGT1A1 polymorphisms to be significantly associated with CAD: OR (95% CI) 0.90 (0.86-0.94), p=2.6 x 10(-6) for men and 0.77 (0.68-0.87), p=3.2 x 10(-5) for women, respectively for each 0.1mg/dl increase of bilirubin. These results indicate that it is rather decreased bilirubin levels in general than the changes in the genetic variation of this gene that increase the risk for CAD.

摘要

血清抗氧化胆红素水平较低与血管老化及冠状动脉疾病(CAD)风险增加相关。UGT1A1是影响胆红素浓度的主要基因。因此,我们在477例早发家族性CAD患者及619例年龄和性别匹配的对照中,研究了胆红素水平与UGT1A1启动子区两个多态性(-53(TA重复)多态性和T-3279G)之间的关联。病例组的胆红素浓度显著低于对照组(男性:0.62±0.36 vs. 0.76±0.41mg/dl,p = 1.2×10⁻¹⁰;女性:0.42±0.29 vs. 0.55±0.23mg/dl,p = 1.9×10⁻⁹)。两种多态性均与胆红素水平密切相关,次要等位基因纯合子携带者的胆红素水平更高。这些关联在男性对照组和患者中最为明显(-53(TA重复)多态性在男性对照组和患者中的p值分别为5.9×10⁻²⁶和3.4×10⁻¹⁶)。逻辑回归分析显示,低胆红素水平而非UGT1A1多态性与CAD显著相关:男性中,胆红素每增加0.1mg/dl,OR(95%CI)为0.90(0.86 - 0.94),p = 2.6×10⁻⁶;女性中,OR(95%CI)为0.77(0.68 - 0.87),p = 3.2×10⁻⁵。这些结果表明,增加CAD风险的是总体胆红素水平的降低,而非该基因遗传变异的改变。